PLEURAL EFFUSION, MALIGNANT
Clinical trials for PLEURAL EFFUSION, MALIGNANT explained in plain language.
Never miss a new study
Get alerted when new PLEURAL EFFUSION, MALIGNANT trials appear
Sign up with your email to follow new studies for PLEURAL EFFUSION, MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists use patients' own lung fluid cells to fight advanced cancer
Disease control Recruiting nowThis early-phase study tests a new treatment for people whose cancer has spread to the lining of the lungs (pleura) or who have mesothelioma. Doctors collect immune cells from the patient's own lung fluid, grow them in a lab, and then put them back into the chest through a tube a…
Matched conditions: PLEURAL EFFUSION, MALIGNANT
Phase: PHASE1 • Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Personalized cell therapy takes on Lung-Lining tumors
Disease control Recruiting nowThis early-phase trial is testing a new immunotherapy called Fast TILs for people with metastatic cancer or mesothelioma that has spread to the pleura (the lining around the lungs). The treatment uses the patient's own immune cells collected from their pleural fluid, which are mu…
Matched conditions: PLEURAL EFFUSION, MALIGNANT
Phase: PHASE1 • Sponsor: David Bartlett, MD • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC